Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQPW9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,454
Award facts
- Contract value 100% obligated
- $31,453.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,453.92 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on December 10, 2025, with an ultimate completion date of January 2, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The contract specifies Park Ridge, Illinois as the place of performance.
This delivery order is issued under DMS Pharmaceutical Group's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract with the Defense Logistics Agency, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents a broader $30.3 billion acquisition strategy designed to provide the Department of Defense with comprehensive pharmaceutical and medical supply chain support globally. DMS Pharmaceutical Group's established performance across multiple delivery orders for diverse pharmaceutical products, including biologics, specialty pharmaceuticals, and routine medications, positions the company as a critical supplier for military healthcare facility operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FQPW9?
SPE2DR26FQPW9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FQPW9 worth?
The government has obligated $31,454 on SPE2DR26FQPW9.
Is contract SPE2DR26FQPW9 an order under another contract?
Yes. SPE2DR26FQPW9 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.
Was contract SPE2DR26FQPW9 competed?
The extent of competition for SPE2DR26FQPW9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award